Trial intelligence / Profile preview

Antioxidants in Stapedotomy (acetylcysteine to prevent hearing damage)

2006-006243-31Phase 4Active

Sponsor
Karolinska University Hospital
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of acetylcysteine in otosclerosis, sponsored by Karolinska University Hospital. Primary endpoint: Change in hearing thresholds at 1 year. Started Mar 2007; status: active.

02

Drugs

acetylcysteine
03

Conditions

otosclerosis

Beyond the preview

Go deeper on 2006-006243-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006243-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call